Marc Lee Melcher, MD
General Surgery · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 4 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
18 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Melcher’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A73407 · Current
Licensed to practise in California · since 2000 · expires 2028-02-29 · Columbia University College of Physicians and Surgeons.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$98,027
Medicare paid this office $98,027 for 94 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Transplantation of donor kidney | 16 | $34,836 | $2,177 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $10,448 | $70 |
| Return visit (30+ min) | 21 | $2,113 | $85 |
| Short return visit (20+ min) | 24 | $1,429 | $55 |
Who their Medicare patients are
94 Original Medicare patients in 2024. Average age 58 · Under 65 56% · Women 38% · Also on Medicaid 59% · Health risk score 7.68. Sicker patients than 9 in 10 peers; the typical general surgery clinician is at 1.69.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 65% · Coronary heart disease 51% · Heart failure 30% · Atrial fibrillation 27% · Depression 20% · Cancer 13% · Stroke 12%.
The office billed $786,250, Medicare allowed $122,466 and paid $98,027; for 302 services of 35 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 94 | 302 | 58 | 7.68 | $786,250 | $98,027 |
| 2023 | 125 | 444 | 60 | 7.43 | $1,056,212 | $125,588 |
| 2022 | 91 | 343 | 58 | 7.02 | $837,676 | $99,782 |
| 2021 | 106 | 317 | 56 | 7.36 | $634,314 | $88,651 |
| 2020 | 120 | 394 | 54 | 7.55 | $725,597 | $127,620 |
| 2019 | 110 | 422 | 57 | 7.24 | $900,869 | $135,699 |
| 2018 | 109 | 346 | 56 | 6.76 | $633,454 | $106,882 |
| 2017 | 99 | 388 | 58 | 6.72 | $734,011 | $120,968 |
| 2016 | 91 | 327 | 58 | 6.19 | $672,970 | $104,493 |
| 2015 | 80 | 309 | 54 | 6.21 | $302,950 | $57,940 |
| 2014 | 105 | 350 | 58 | 5.88 | $479,944 | $82,324 |
| 2013 | 107 | 338 | 54 | 6.84 | $565,366 | $109,831 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Transplantation of donor liver | 16 | $53,020 | $3,314 |
| Transplantation of donor kidney | 14 | $30,556 | $2,183 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 60 | $16,344 | $72 |
| Return visit (30+ min) | 35 | $3,704 | $90 |
| Short return visit (20+ min) | 46 | $3,431 | $59 |
2022: 4 services
| Transplantation of donor liver | 17 | $53,018 | $3,119 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 50 | $13,130 | $65 |
| Short return visit (20+ min) | 41 | $2,849 | $59 |
| Return visit (30+ min) | 18 | $1,891 | $90 |
2021: 4 services
| Transplantation of donor liver | 12 | $36,027 | $3,002 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 38 | $8,188 | $66 |
| Short return visit (20+ min) | 54 | $5,099 | $59 |
| Return visit (30+ min) | 19 | $2,264 | $91 |
2020: 5 services
| Transplantation of donor kidney | 25 | $53,684 | $2,147 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 48 | $9,689 | $67 |
| Short return visit (20+ min) | 55 | $3,901 | $47 |
| Return visit (30+ min) | 26 | $2,366 | $74 |
| Preparation of donor kidney for transplantation | 22 | $1,748 | $79 |
2019: 6 services
| Transplantation of donor liver | 17 | $50,592 | $2,976 |
| Transplantation of donor kidney | 23 | $47,467 | $2,064 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 57 | $11,618 | $66 |
| Return visit (30+ min) | 35 | $3,301 | $72 |
| Short return visit (20+ min) | 44 | $2,972 | $46 |
| Preparation of donor kidney for transplantation | 20 | $1,547 | $77 |
2018: 7 services
| Transplantation of donor kidney | 19 | $39,035 | $2,054 |
| Transplantation of donor liver | 11 | $32,867 | $2,988 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $8,584 | $63 |
| Return visit (30+ min) | 39 | $3,700 | $66 |
| Short return visit (20+ min) | 29 | $1,520 | $39 |
| Preparation of donor kidney for transplantation | 14 | $1,087 | $78 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $679 | $34 |
2017: 7 services
| Transplantation of donor liver | 17 | $61,956 | $3,644 |
| Transplantation of donor kidney | 14 | $29,640 | $2,117 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 38 | $10,430 | $65 |
| Return visit (30+ min) | 39 | $4,585 | $68 |
| Short return visit (20+ min) | 37 | $2,510 | $46 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $768 | $35 |
| Preparation of donor kidney for transplantation | 11 | $717 | $65 |
2016: 7 services
| Transplantation of donor liver | 14 | $42,685 | $3,049 |
| Transplantation of donor kidney | 14 | $29,686 | $2,120 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $7,973 | $64 |
| Return visit (30+ min) | 32 | $3,292 | $70 |
| Short return visit (20+ min) | 37 | $1,868 | $43 |
| Preparation of donor kidney for transplantation | 11 | $872 | $79 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $663 | $35 |
2015: 4 services
| Transplantation of donor kidney | 12 | $25,039 | $2,087 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $7,764 | $65 |
| Return visit (30+ min) | 34 | $3,006 | $70 |
| Short return visit (20+ min) | 33 | $2,138 | $45 |
2014: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $9,748 | $63 |
| Return visit (30+ min) | 43 | $5,524 | $70 |
| Short return visit (20+ min) | 24 | $1,456 | $45 |
| Short return visit | 11 | $223 | $20 |
2013: 5 services
| Transplantation of donor kidney | 27 | $61,162 | $2,265 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $5,785 | $62 |
| Return visit (30+ min) | 38 | $3,185 | $65 |
| Short return visit (20+ min) | 42 | $2,484 | $42 |
| Preparation of donor kidney for transplantation | 19 | $1,643 | $86 |
Medicaid work
$2,419 in 2023
Medicaid paid $2,419 for 89 billed services this clinician did in 2023, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 89 | $2,419 |
| 2023 | 89 | 1 | 17 | $2,419 |
| 2022 | 23 | 1 | 12 | $535 |
See the largest Medicaid services in earlier years
2022
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 23 | $535 |
Drugs they prescribed that Part D paid
$56,544
Pharmacies billed $56,544 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 777) in 2024. At or below the middle of the specialty; the typical general surgery clinician is at 34%.
659 generic and 66 brand-name prescriptions · $56,544 in drug cost · 169 antibiotic prescriptions to 30 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mycophenolate Mofetil | 20 | $10,102 | $505 |
| Atovaquone | 15 | $5,524 | $368 |
| Valganciclovir | 56 | $4,088 | $73 |
| Insulin Lispro Kwikpen U-100 | 22 | $3,450 | $157 |
| Comfort Ez Pen Needle | 23 | $2,650 | $115 |
See all 19 drugs
| Mycophenolate Mofetil | 20 | $10,102 | $505 |
| Atovaquone | 15 | $5,524 | $368 |
| Valganciclovir | 56 | $4,088 | $73 |
| Insulin Lispro Kwikpen U-100 | 22 | $3,450 | $157 |
| Comfort Ez Pen Needle | 23 | $2,650 | $115 |
| Ultra-Fine Nano Pen Needle | 20 | $1,405 | $70 |
| Nystatin | 21 | $677 | $32 |
| Sulfamethoxazole-Trimethoprim | 160 | $217 | $1 |
| Pantoprazole | 45 | $153 | $3 |
| Famotidine | 44 | $138 | $3 |
| Prednisone | 23 | $119 | $5 |
| Metoprolol | 16 | $118 | $7 |
| Carvedilol | 23 | $101 | $4 |
| Amlodipine Besylate | 56 | $100 | $2 |
| Hydroxychloroquine Sulfate | 12 | $91 | $8 |
| Rosuvastatin | 14 | $42 | $3 |
| Furosemide | 13 | $32 | $2 |
| Clonidine | 13 | $29 | $2 |
| Atorvastatin | 17 | $19 | $1 |
Year by year
| 2024 | 777 | 72 | 0% (0) | 8% | $56,544 |
| 2023 | 1,105 | 83 | 0% (0) | 9% | $116,060 |
| 2022 | 1,069 | 69 | None | 9% | $87,853 |
| 2021 | 895 | 83 | None | 8% | $71,505 |
| 2020 | 1,166 | 96 | 0% (0) | 9% | $133,888 |
| 2019 | 1,090 | 89 | None | 10% | $146,444 |
| 2018 | 1,227 | 63 | None | 12% | $148,455 |
| 2017 | 890 | 72 | None | 10% | $141,241 |
| 2016 | 1,158 | 70 | None | 12% | $168,070 |
| 2015 | 672 | 63 | None | 8% | $74,891 |
| 2014 | 969 | 76 | 3% (30) | 20% | $175,444 |
| 2013 | 957 | 76 | 3% (33) | 18% | $158,644 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 26 drugs
| Novolog Flexpen | 52 | $31,909 | $614 |
| Atovaquone | 11 | $11,702 | $1,064 |
| Tacrolimus | 13 | $9,981 | $768 |
| Valganciclovir | 76 | $9,648 | $127 |
| Comfort Ez Pen Needle | 28 | $2,631 | $94 |
| Nystatin | 51 | $2,310 | $45 |
| Ultra-Fine Nano Pen Needle | 26 | $1,797 | $69 |
| Famotidine | 87 | $1,626 | $19 |
| Mycophenolate Mofetil | 14 | $1,174 | $84 |
| Amlodipine Besylate | 80 | $894 | $11 |
| Sulfamethoxazole-Trimethoprim | 157 | $792 | $5 |
| Diltiazem 24hr Er (Cd) | 13 | $547 | $42 |
| Metoprolol | 31 | $544 | $18 |
| Prednisone | 31 | $539 | $17 |
| Carvedilol | 31 | $484 | $16 |
| Clonidine | 26 | $483 | $19 |
| Levothyroxine | 29 | $336 | $12 |
| Gabapentin | 20 | $304 | $15 |
| Tamsulosin | 32 | $270 | $8 |
| Omeprazole | 12 | $245 | $20 |
| Metoclopramide | 13 | $210 | $16 |
| Furosemide | 22 | $201 | $9 |
| Pantoprazole | 20 | $200 | $10 |
| Fludrocortisone Acetate | 13 | $146 | $11 |
| Atorvastatin | 15 | $119 | $8 |
| Acyclovir | 12 | $117 | $10 |
2022: 23 drugs
| Novolog Flexpen | 28 | $16,455 | $588 |
| Lantus Solostar | 21 | $9,269 | $441 |
| Valganciclovir | 71 | $8,423 | $119 |
| Comfort Ez Pen Needle | 51 | $5,307 | $104 |
| Mycophenolate Mofetil | 18 | $4,897 | $272 |
| Nystatin | 30 | $1,279 | $43 |
| Famotidine | 64 | $672 | $11 |
| Sulfamethoxazole-Trimethoprim | 182 | $529 | $3 |
| Amlodipine Besylate | 69 | $391 | $6 |
| Fludrocortisone Acetate | 18 | $385 | $21 |
| Clonidine | 29 | $342 | $12 |
| Prednisone | 41 | $335 | $8 |
| Pantoprazole | 52 | $224 | $4 |
| Levothyroxine | 25 | $207 | $8 |
| Carvedilol | 26 | $178 | $7 |
| Metoprolol | 29 | $174 | $6 |
| Furosemide | 28 | $155 | $6 |
| Omeprazole | 14 | $142 | $10 |
| Tamsulosin | 28 | $117 | $4 |
| Paroxetine | 11 | $105 | $10 |
| Calcitriol | 13 | $99 | $8 |
| Gabapentin | 13 | $80 | $6 |
| Atorvastatin | 14 | $52 | $4 |
2021: 21 drugs
| Valganciclovir | 74 | $10,263 | $139 |
| Novolog Flexpen | 17 | $10,055 | $591 |
| Cinacalcet | 15 | $5,746 | $383 |
| Lantus Solostar | 12 | $5,315 | $443 |
| Comfort Ez Pen Needle | 28 | $2,843 | $102 |
| Tacrolimus | 13 | $2,729 | $210 |
| Nystatin | 32 | $1,061 | $33 |
| Famotidine | 85 | $803 | $9 |
| Sulfamethoxazole-Trimethoprim | 138 | $560 | $4 |
| Prednisone | 39 | $366 | $9 |
| Clonidine | 34 | $315 | $9 |
| Amlodipine Besylate | 56 | $307 | $5 |
| Fludrocortisone Acetate | 17 | $262 | $15 |
| Carvedilol | 29 | $209 | $7 |
| Pantoprazole | 24 | $163 | $7 |
| Tamsulosin | 12 | $141 | $12 |
| Metoprolol | 33 | $129 | $4 |
| Furosemide | 31 | $118 | $4 |
| Levothyroxine | 12 | $118 | $10 |
| Atorvastatin | 17 | $67 | $4 |
| Trazodone | 12 | $31 | $3 |
2020: 24 drugs
| Vemlidy | 20 | $24,427 | $1,221 |
| Ozempic | 19 | $15,677 | $825 |
| Novolog Flexpen | 25 | $14,443 | $578 |
| Valganciclovir | 77 | $10,978 | $143 |
| Comfort Ez Pen Needle | 44 | $3,973 | $90 |
| Nystatin | 52 | $2,020 | $39 |
| Mycophenolate Mofetil | 18 | $889 | $49 |
| Famotidine | 101 | $792 | $8 |
| Ultra-Fine Short Pen Needle | 11 | $771 | $70 |
| Sulfamethoxazole-Trimethoprim | 212 | $594 | $3 |
| Amlodipine Besylate | 95 | $456 | $5 |
| Pantoprazole | 57 | $439 | $8 |
| Metoprolol | 62 | $343 | $6 |
| Fludrocortisone Acetate | 23 | $341 | $15 |
| Clonidine | 29 | $227 | $8 |
| Prednisone | 30 | $222 | $7 |
| Atorvastatin | 31 | $141 | $5 |
| Furosemide | 33 | $141 | $4 |
| Rosuvastatin | 12 | $140 | $12 |
| Carvedilol | 17 | $106 | $6 |
| Trimethoprim | 13 | $77 | $6 |
| Omeprazole | 15 | $74 | $5 |
| Tamsulosin | 12 | $52 | $4 |
| Glipizide | 11 | $41 | $4 |
2019: 23 drugs
| Valganciclovir | 65 | $24,919 | $383 |
| Novolog Flexpen | 28 | $17,436 | $623 |
| Vemlidy | 15 | $17,356 | $1,157 |
| Victoza 3-Pak | 13 | $12,306 | $947 |
| Comfort Ez Pen Needle | 34 | $3,905 | $115 |
| Nystatin | 36 | $1,603 | $45 |
| Clotrimazole | 12 | $932 | $78 |
| Pantoprazole | 98 | $855 | $9 |
| Famotidine | 92 | $705 | $8 |
| Mycophenolate Mofetil | 15 | $578 | $39 |
| Sulfamethoxazole-Trimethoprim | 154 | $465 | $3 |
| Amlodipine Besylate | 88 | $440 | $5 |
| Clonidine | 28 | $320 | $11 |
| Metoprolol | 61 | $307 | $5 |
| Levothyroxine | 22 | $267 | $12 |
| Acyclovir | 19 | $191 | $10 |
| Tamsulosin | 31 | $174 | $6 |
| Glipizide | 38 | $163 | $4 |
| Prednisone | 28 | $160 | $6 |
| Atorvastatin | 31 | $138 | $4 |
| Ciprofloxacin | 11 | $129 | $12 |
| Furosemide | 20 | $115 | $6 |
| Carvedilol | 14 | $110 | $8 |
2018: 23 drugs
| Valganciclovir | 86 | $49,377 | $574 |
| Vemlidy | 36 | $39,686 | $1,102 |
| Novolog Flexpen | 29 | $17,539 | $605 |
| Tacrolimus | 57 | $10,483 | $184 |
| Mycophenolate Mofetil | 39 | $2,716 | $70 |
| Nystatin | 60 | $2,589 | $43 |
| Comfort Ez Pen Needle | 16 | $1,464 | $91 |
| Tamsulosin | 62 | $551 | $9 |
| Pantoprazole | 85 | $551 | $6 |
| Amlodipine Besylate | 97 | $486 | $5 |
| Famotidine | 110 | $478 | $4 |
| Levothyroxine | 36 | $473 | $13 |
| Sulfamethoxazole-Trimethoprim | 149 | $471 | $3 |
| Unifine Pentips | 12 | $429 | $36 |
| Metoprolol | 70 | $374 | $5 |
| Prednisone | 32 | $346 | $11 |
| Clonidine | 29 | $313 | $11 |
| Fludrocortisone Acetate | 17 | $253 | $15 |
| Carvedilol | 27 | $214 | $8 |
| Furosemide | 26 | $142 | $5 |
| Gabapentin | 11 | $104 | $9 |
| Glipizide | 20 | $80 | $4 |
| Isoniazid | 11 | $70 | $6 |
2017: 16 drugs
| Valganciclovir | 82 | $83,793 | $1,022 |
| Lantus | 11 | $2,794 | $254 |
| Nystatin | 50 | $2,332 | $47 |
| Mycophenolate Mofetil | 12 | $814 | $68 |
| Pantoprazole | 100 | $695 | $7 |
| Sulfamethoxazole-Trimethoprim | 150 | $538 | $4 |
| Tamsulosin | 28 | $461 | $16 |
| Famotidine | 82 | $339 | $4 |
| Metoprolol | 63 | $326 | $5 |
| Amlodipine Besylate | 66 | $317 | $5 |
| Warfarin | 13 | $314 | $24 |
| Prednisone | 15 | $263 | $18 |
| Pen Needles | 11 | $217 | $20 |
| Levothyroxine | 14 | $196 | $14 |
| Furosemide | 29 | $145 | $5 |
| Glipizide | 21 | $98 | $5 |
2016: 26 drugs
| Valganciclovir | 86 | $82,076 | $954 |
| Viread | 13 | $13,062 | $1,005 |
| Novolog Flexpen | 24 | $11,684 | $487 |
| Humalog Kwikpen U-100 | 21 | $9,883 | $471 |
| Tacrolimus | 22 | $7,361 | $335 |
| Lantus Solostar | 13 | $4,623 | $356 |
| Nystatin | 62 | $2,979 | $48 |
| Mycophenolate Mofetil | 14 | $1,599 | $114 |
| Pen Needles | 50 | $840 | $17 |
| Hydroxychloroquine Sulfate | 11 | $838 | $76 |
| Pantoprazole | 102 | $614 | $6 |
| Sulfamethoxazole-Trimethoprim | 156 | $479 | $3 |
| Levothyroxine | 34 | $463 | $14 |
| Tamsulosin | 27 | $421 | $16 |
| Famotidine | 78 | $359 | $5 |
| Amlodipine Besylate | 72 | $311 | $4 |
| Metoprolol | 68 | $223 | $3 |
| Carvedilol | 32 | $209 | $7 |
| Clonidine | 25 | $189 | $8 |
| Diltiazem 24hr Cd | 12 | $184 | $15 |
| Prednisone | 16 | $137 | $9 |
| Furosemide | 45 | $131 | $3 |
| Glipizide | 25 | $88 | $4 |
| Isosorbide Mononitrate Er | 12 | $86 | $7 |
| Clopidogrel | 12 | $43 | $4 |
| Terazosin | 13 | $35 | $3 |
2015: 16 drugs
| Valganciclovir | 49 | $39,275 | $802 |
| Novolog Flexpen | 13 | $5,422 | $417 |
| Nystatin | 35 | $1,549 | $44 |
| Sulfamethoxazole-Trimethoprim | 111 | $449 | $4 |
| Metoprolol | 64 | $411 | $6 |
| Pantoprazole | 34 | $334 | $10 |
| Prednisone | 30 | $317 | $11 |
| Famotidine | 48 | $302 | $6 |
| Pen Needles | 15 | $297 | $20 |
| Tamsulosin | 15 | $241 | $16 |
| Amlodipine Besylate | 34 | $155 | $5 |
| Omeprazole | 12 | $115 | $10 |
| Furosemide | 13 | $87 | $7 |
| Clonidine | 13 | $86 | $7 |
| Carvedilol | 13 | $53 | $4 |
| Terazosin | 12 | $44 | $4 |
2014: 21 drugs
| Valcyte | 75 | $91,526 | $1,220 |
| Tacrolimus | 33 | $30,272 | $917 |
| Humalog | 21 | $7,442 | $354 |
| Novolog Flexpen | 18 | $6,561 | $365 |
| Nystatin | 48 | $3,193 | $67 |
| Mycophenolate Mofetil | 20 | $1,952 | $98 |
| Famotidine | 99 | $638 | $6 |
| Pantoprazole | 34 | $603 | $18 |
| Metoprolol | 68 | $558 | $8 |
| Omeprazole | 57 | $553 | $10 |
| Sulfamethoxazole-Trimethoprim | 98 | $450 | $5 |
| Insulin | 17 | $440 | $26 |
| Pen Needles | 16 | $430 | $27 |
| Tamsulosin | 31 | $296 | $10 |
| Hydrocodone-Acetaminophen | 19 | $293 | $15 |
| Prednisone | 25 | $263 | $11 |
| Carvedilol | 32 | $205 | $6 |
| Furosemide | 30 | $123 | $4 |
| Atorvastatin | 11 | $101 | $9 |
| Terazosin | 11 | $64 | $6 |
| Amlodipine Besylate | 11 | $42 | $4 |
2013: 19 drugs
| Valcyte | 102 | $114,710 | $1,125 |
| Tacrolimus | 20 | $9,748 | $487 |
| Nystatin | 76 | $4,653 | $61 |
| Mycophenolate Mofetil | 25 | $2,185 | $87 |
| Famotidine | 108 | $900 | $8 |
| Metoprolol | 78 | $582 | $7 |
| Sulfamethoxazole-Trimethoprim | 120 | $516 | $4 |
| Tamsulosin | 40 | $498 | $12 |
| Pantoprazole | 21 | $458 | $22 |
| Hydrocodone-Acetaminophen | 28 | $336 | $12 |
| Omeprazole | 28 | $323 | $12 |
| Amlodipine Besylate | 47 | $312 | $7 |
| Insulin | 16 | $308 | $19 |
| Furosemide | 28 | $194 | $7 |
| Levothyroxine | 16 | $154 | $10 |
| Amiodarone | 12 | $131 | $11 |
| Glipizide | 22 | $129 | $6 |
| Prednisone | 14 | $123 | $9 |
| Ciprofloxacin | 15 | $46 | $3 |
Money from drug and device companies
$401 in 2025
| 2025 | 2 | 5 | None | $401 |
| 2024 | 2 | 5 | None | $3,065 |
| 2023 | 2 | 4 | None | $1,512 |
| 2022 | 1 | 2 | None | $249 |
| 2021 | 1 | 1 | None | $50 |
| 2019 | 1 | 1 | None | $124 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ethicon US | Surgicel Nu-Knit | $207 | 3 payments
|
| Paragonix Technologies | Kidneyvault | $195 | 2 payments
|
See all 5 published payments
| Ethicon US | Meals · 2025-11-03 | Surgicel Nu-Knit | $51 |
| Ethicon US | Meals · 2025-10-31 | Surgicel Nu-Knit | $125 |
| Ethicon US | Meals · 2025-10-27 | Surgicel Nu-Knit | $31 |
| Paragonix Technologies | Meals · 2025-09-24 | Kidneyvault | $138 |
| Paragonix Technologies | Meals · 2025-09-02 | Kidneyvault | $57 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $3,065
| TransMedics | Organ Care System | $2,759 | 2 payments
|
| Ethicon US | Stratafix | $305 | 3 payments
|
2023: $1,512
| TransMedics | Organ Care System | $1,317 | 1 payment
|
| Ethicon US | Echelon Flex | $195 | 3 payments
|
2022: $249
| Ethicon US | Echelon; Endopath | $249 | 2 payments
|
2021: $50
| Conmed | Abc Handpieces | $50 | 1 payment
|
2019: $124
| Novartis Pharmaceuticals | Zortress | $124 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Paragonix Technologies, Inc. · Observational Study of Liver Preservation · 2024 | Their institution | $37,165 |
| TRANSMEDICS, INC. · Ocs Liver Perfusion (Olp) · 2025 | Their institution | $8,955 |
| Paragonix Technologies, Inc. · Global Utilization and Registry Database for Improved Preservation of Donor Livers · 2022 | Their institution | $8,704 |
| Paragonix Technologies, Inc. · Global Utilization and Registry Database for Improved Preservation of Donor Livers · 2023 | Their institution | $6,915 |
| Paragonix Technologies, Inc. · Observational Study of Liver Preservation · 2025 | Their institution | $1,915 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1003870486
- Licence
- CA A73407California A73407: Current · expires 2028-02-29
- Trained
- Columbia University College of Physicians and Surgeons, 1999
- Group
- Stanford Health Care
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A734070
- Taxonomy
- Federal specialty code 204F00000X (204F00000X); Surgery (208600000X)
- Mailing address
- 725 Welch Rd, Palo Alto, CA, 94304
- NPI first listed
- 2006-04-13
- NPI last updated
- 2026-09-02
- NPI record certified
- 2026-09-02
This is when the NPI record was last certified, not a medical board exam.